Kolexia
Dreanic Johann
Gastro-entérologie
Hôpital Cochin
Paris, France
68 Activités
460 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Adénocarcinome Tumeurs colorectales Métastase tumorale Carcinomes Tumeurs gastro-intestinales Tumeurs du pancréas Polypes intestinaux Tumeurs neuroendocrines Polypes coliques

Industries

Merck-Serono
1 collaboration(s)
Dernière en 2021
VIATRIS MEDICAL
1 collaboration(s)
Dernière en 2022
Boston Scientific
1 collaboration(s)
Dernière en 2021
APOLLO ENDOSURGERY UK
1 collaboration(s)
Dernière en 2021

Dernières activités

ADAGE: Randomised Phase III Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over Intergroup Trial: Ffcd, Gercor, Gerico, Unicancer-gi
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study.
Clinics and research in hepatology and gastroenterology   27 avril 2021
Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management.
Targeted oncology   13 mars 2018
Small bowel capsule endoscopy: May we delegate it to nurses?
Clinics and research in hepatology and gastroenterology   24 novembre 2017
Clipping after large colorectal polyp resections reduces adverse events and allows ambulatory management.
Gastrointestinal endoscopy   17 octobre 2017
Self-expandable metal stent through the tumor to treat an intestinal obstruction due to pancreatic squamous cell carcinoma.
VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy   12 octobre 2017
Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study.
Oncotarget   08 septembre 2017
Gastric Carcinoma at the Era of Targeted Therapies.
Current drug targets   30 août 2017
Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers.
Investigational new drugs   01 août 2017
Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: A multicenter AGEO study.
2017 Gastrointestinal Cancers Symposium   21 mars 2017